WIPO
open access
New role of extemporaneous manufacturing in regulating drug products access onto the market
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Strategic Submissions : An Analysis of Supplemental Drug Approvals#971047
- "Market Shift Liability" for Generic Drugs: Market Share Theory's Eccentric New Cousin#212295
- Drug Labels as Evidence of Patent Infringement — A Troubling Legal Trend#333967
- Drug Regulation Contradiction: The Paradox of Overregulation in Japan and Beyond#119826
- A Regulatory Science for Medical Devices with Continuously Changing Properties in the Post-Marketing Phase#22656
Record · ID 163553
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive